Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

JOURNAL ARTICLE published 21 July 2022 in New England Journal of Medicine

Research funded by Merck (N/A)

Authors: Javier Cortes | Hope S. Rugo | David W. Cescon | Seock-Ah Im | Mastura M. Yusof | Carlos Gallardo | Oleg Lipatov | Carlos H. Barrios | Jose Perez-Garcia | Hiroji Iwata | Norikazu Masuda | Marco Torregroza Otero | Erhan Gokmen | Sherene Loi | Zifang Guo | Xuan Zhou | Vassiliki Karantza | Wilbur Pan | Peter Schmid